Clinical Trial Update: SPIROCOR Coronary Outcome by Respiratory Stress Examination

View source ↗

Summary

Clinical trial SPIROCOR investigating coronary outcomes using respiratory stress examination has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Spirocor | Conditions: Severe Coronary Artery Disease (S-CAD) | Status: TERMINATED